It was reported that CASC7 retarded the progression of multiple cancers, such as papillary thyroid carcinoma, neuroblastoma, glioma and non-small-cell lung cancer [9,10,26,27]. This evidence concerns the gene AGO2 and differentiated thyroid carcinoma.